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The recognition of foreign antigen is one of the key events in the induction of
an immune response. It is now accepted thatT lymphocytes recognize a fragment
of antigen bound to anMHC molecule (1-7) . The discovery that the antigen frag-
ments that bind to MHC molecules and are recognized by T cells can be repre-
sented by linear synthetic peptides has greatly facilitated the elucidationof the exact
nature ofantigenrecognition (8-11) . In this model, theantigenmust be able to simul-
taneously contact the MHC molecule as well as the TCR (12), features that have
been termed agretopes and epitopes, respectively, by Heber-Katz et al . (13) . There
have now been many different peptide determinants that have been analyzed in de-
tail, including hen egg-white lysozyme (14), ovalbumin (15), and moth/pigeon
cytochrome c (16) . Several differentapproaches have been used in these studies ; how-
ever, they all share acommon feature in that they determined the effect of single
amino acid substitutionson the function ofa peptideantigen . The main conclusions
reached by these authors are that individual residues in an immunogenic peptide
can be identified as TCR contact residues orMHC molecule binding residues . These
amino acid residues are not grouped together, but are instead interspersed among
each other and among nonessential residues . Despite these studies, it is still unclear
as to how and where a peptide precisely binds to aMHC molecule and what is the
conformation of a peptide as it is bound and recognized by the TCR.
In the studies described below, we have approached this problem ofMHC-peptide-
TCR interaction by determining which residues in an immunogenic peptide are
crucial for antigen-specific TCR recognition . Our working hypothesis was that if
certain amino acid residues in a peptideare critical forT cell recognition, then these
crucial residues should be sufficient to completely reconstitute antigen-specific T
cell recognition when the residues are put in the context of an unrelated peptide
backbone . We have taken the experimental approach of initially substituting an ala-
nine residue at each position of a peptide antigen, and then testing these peptides
for activity . From these results, a second generation of peptides was designed, syn-
thesized, and tested, with the overall goal of this work being to identify the residues
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that are critical for the formation of a peptide determinant . In this manuscript, we
report on the analysis of the I-Al'-restricted determinant RNase(43-56), from which
we were able to identify the critical residues. These five identified residues were then
substituted onto an unrelated peptide backbone and the resulting peptide was tested
for its ability to stimulate an RNase-specific T cell hybridoma. The 15 amino acid
hybrid peptide, which contains only five residues from the RNase determinant, was
able to stimulate the RNase(43-56)-specific T cell hybridoma in a manner similar
to that of the RNase(43-56) peptide. In addition, when tested in vivo this chimeric
peptide was able to prime T cells to respond to the bovine RNase molecule.
Materials and Methods
RNase-speck T Cell Hybridoma. The generation and characterization of the I-Ak-
restricted, RNase-specific T cell hybridoma TS12 has been previously described in detail (17).
TCell Stimulation Assay. The stimulation of T cell hybridomas was performed exactly as
previously described (17, 18). The source of APCs were peptone elicited peritoneal macro-
phages from CBA/J mice that had been previously infected with Listeria monocytogenes. The
macrophage monolayers were fixed in 0 .1% gluteraldehyde before exposure to antigen. To
these fixed monolayers of macrophages, various concentrations of the peptide antigens were
added alongwith 105 TS12 T cell hybridomas. The level of stimulation was then determined
by quantitating the level of IL-2 production by [3H]thymidine incorporation into the IL-2-
dependent cell line CTLL-2. For competition assays, the competing and stimulating antigens
were added sequentially and were present throughout the entire culture period.
TCell Proliferation Assay.
￿
Two CBA/J mice were primed in each of the rear foot pads with
20 nmol or 50 nmol of antigen emulsified in CFA (H37Ra, Adjuvant Complete Difco Labora-
tories, Inc., Detroit, MI). 7-10 d later the popliteal lymph nodes were removed, pooled, and
a single cell suspension was prepared. These cells were cultured in 96 well microtiter plates
(No. 3596; Costar, Cambridge, MA) in a total volume of 0.2 ml. The culture medium con-
sisted of RPMI 1640 supplemented with 2 MM L-Glutamine, 1 mM Hepes, 1 mM sodium
pyruvate, 50 U/ml penicillin, 50 Ag/ml streptomycin, 5 x 10-5 M 2-ME, and 0.5% (vol/vol)
of freshly obtained autologous normal mouse serum . Each antigen was tested at concentra-
tions from 100 to 0.01 gM . The background proliferation was determined from cultures that
contained medium alone. The cultures were incubated at 37°C for 96 h, with each well being
pulsed with 0.4 itCi of [3H]thymidine for the last 18 h of the culture. Each group contained
a positive control that consisted of wells containing purified protein derivative (PPD,' 100
wg/ml).
Peptide Synthesis, Purification, andAnalysis.
￿
All of the peptides were synthesized manually
using the FMOC strategy on a RaMPSTM multiple peptide synthesis system (DuPont Co.,
Wilmington, DE) (19). Each peptide was purified using reverse-phase, high-pressure liquid
chromatography (14, 20). The composition of each peptide was verified by fast atom bom-
bardment mass spectrometry (21).
Results
Localization oftheRNase(43-56) Determinant.
￿
We had previously shown that TS12
cells recognize a determinant of bovine RNase contained in residues 40-61 (17) .
To further localize this determinant we generated a series of overlapping 15 mers
covering the entire 40-61 sequence. These peptides were then tested for their ability
to stimulate TS12 (Fig. 1). Four of these peptides (41-55, 42-56, 43-57, and 44-58)
stimulated the TS12 cells, whereas the 45-59 and 46-60 (data not shown) did not
' Abbreviations used in this paper: cIR, bacteriophage Xcl; HA, hemagglutinin; Matrix, influenza ma-
trix protein; Nase, staphylococcal nuclease; PPD, purified protein derivative; RNase, bovine ribonuclease.c
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stimulate even at 100 uM . Of the peptides tested, 42-56 and 43-57 were the most
stimulatory, although both were 10-fold less potent than 41-61. From these results
we chose the 14-mer 43-56 to use as the core sequence for our further investigations
(Table I).
Identification of the Critical Residues of RNase(43-56).
￿
To identify the amino acid
residues in the RNase(43-56) molecule that were critical in the formation of the
determinant recognized by the TS12 cells, we used the strategy of testing peptides
containing single amino acid substitutions. Initially a series of single alanine sub-
stituted peptides were tested to identify potential critical residues. At positions that
contained an alanine residue in the native sequence, a serine residue was substituted.
If a substitution with an alanine residue significantly altered the activity of the pep-
tide, then that position was then further examined by a series of peptides that con-
tained conservative amino acid substitutions. Shown in Fig. 2 are the results when
each of the alanine substituted peptides were tested for their ability to stimulate TS12
cells. Single alanine substitutions at four positions dramatically decreased the potency
of the peptides, those being at positions 46, 47, 48, and 51. All of the other peptides
TABLE I
Amino Acid Sequence of RNase(43-56) and Related Peptides
LORENZ ET AL.
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FIGURE 1.
￿
Stimulation of TS12 cells by a series of
nested 15-mers of RNase(41-61). The T cell stimu-
lation assay was performed as described in the Mate-
rials and Methods. RNase(41-61), RNase(41-55),
RNase(42-56), RNase(43-57), RNase(44-58), and
RNase(45-59) were cultured continuously with fixed
macrophages and TS12 cells at concentrations from
0.001 to 10 JIM.
56
A
The amino acid sequence ofthe bovine ribonuclease determinant RNase(43-56)
and that of peptides containing substitutions are shown. The standard single-
letter codes for the amino acids are used. The numbers refer to the position num-
bers in the native bovine ribonuclease molecule (30). The designation ofthe pep-
tide and the position of the substituted residues in the peptides are shown. The
solid line indicates homology with the residues in the native RNase(43-56)
molecule.
Designation Sequence
43 44 45 46 47 48 49 50 51 52 53 54 55
RNase(43-56) V N T F V H E S L A D V Q
Y46 Y
R48 R
151 1206
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FIGURE 2 .
￿
An alanine scan ofthe
RNase(43-56) determinant . A se-
ries of peptides were synthesized
that contained single alanine sub-
stitutions at each of the indicated
positions . A serine residuewas sub-
stituted for the alanine residues
found in the native sequence . Each
peptide was tested for its ability to
stimulateTS12 cells over a concen-
tration range of 0.01 to 100 pM
using the assay conditions described
in the Materials and Methods . The
relative stimulatory capacity ofeach
peptide was determined from the
ratio of the concentration of the
substituted peptide required for a
50% maximal response to the same
value determined for the native
RNase(43-56) molecule. The
100% value was themaximal value
obtained from stimulation with the
native RNase(43-56). Thus, a
value of0.1 indicated that 10 times
more of the substituted peptide
than of RNase(43-56) was required
to achieve the same level of stimu-
lation .The solid bar represents the
response of the native peptide
RNase(43-56) . The values shown
are from single experiment and this
experiment has been performed
twice with identical results.
stimulated TS12 in an unaltered or slightly decreased manner. Eight positions, in-
cluding the four identified from the alanine scan, were then further examined by
conservative substitutions . A summary of these results is shown in Fig . 3 . Of the
four potentially critical residues, three ofthem showed remarkable specificity. The
Phe-46 when replaced with atyrosine residue was totally inactive, and likewise, the
substitution ofthe His-48 with either an arginine or a glutamineresiduealso resulted
in completely inactive peptides . The Leu-51 position showed remarkable specificity
in that isoleucine and valine substitutions were not active, while a norleucine substi-
tution was only very weakly active . At position Val-47 there appeared to be less
specificity in that an isoleucine residue was fully active, while a leucine or alanine
substitution was much less active . Other positions which were similarly examined
were the Glu-49, Ser-50, Ala-52, andVal-54 . TheGlu-49 residue could be replaced
with nonconservative substitutions including an alanine or a glycine residue . In a
similar manner, the Ala-52 could be replaced with a serine ora glycine and the Val-
54 could be replaced with an alanine or isoleucine . We had previously examined
position 50 in detail since this is the only position that differs from the self murine
RNase molecule. Wehad found that awide varietyof residues could be substituted,
and only the extreme substitution ofa proline residue (which is the corresponding
residue in the murine RNase sequence) resulted in the loss of activity (17) . Substitu-
tions at two positions, an isoleucine for the valine at position 47 and a glycine forLORENZ ET AL.
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FIGURE 3.
￿
Asummary of the response ofTS12
cells to peptides containing single amino acid sub-
stitutions ofRNase(43-56).The position number
and amino acid residue normally found in
RNase(43-56) are indicated on the top ofthe fig-
ure. The designations at the bottom are the single-
letter amino acid codes for peptides containing
this single substitution for the indicated amino
acid residue. For example, theAunder the F46,
represents the peptide Ala-46, RNase(43-56) .
The standard one-letter code for amino acid resi-
dues are used except Nl for norleucine residues .
The relative stimulatory capacity was determined
as described in Fig . 2 .The dotted line indicates the
level ofthe response to the native RNase(43-56)
peptide. The values are compiled from six sepa-
rate experiments and each peptide has been tested
in at least three independent experiments. The
values for the alanine substitutions are from the
experiment shown in Fig . 2 .
the alanine at position 52 resulted in peptides with enhanced stimulatory character-
istics . From this analysiswe concluded that three ofthe four potentially critical posi-
tions; residues Phe-46, His-48, and Leu-51 had very stringent requirements and
could not be replaced even with very conservative substitutions . In contrast, theVal-
47 showed less specificity in that it could be replaced with an isoleucine residue.
Reconstruction oftheRNase(43-56) Determinant by Transferring the Critical Residues into
an Unrelated Peptide. To directly demonstrate the crucial nature ofthese four poten-
tially critical residues, we generated chimeric peptides in which these residues were
substituted onto an unrelated peptide backbone . If these residues were the crucial
residues for the formationof the RNase(43-56) determinant thenwe should be able
to insert only these four residues into another peptide backbone, and consequently
transfer the RNase(43-56) specificity. Thepeptidebackbone that we chose was the
determinant ofinfluenza hemagglutinin (HA) contained in the residues HA(130-142)
(22) . This peptide had been previously shown to bind to both I-Ak and I-Ad mole-
cules and to contain an amino acid motiffound in I-Ad binding peptides (VTAACS)
(23) . The I-Ad motif is a sequence ofamino acid residues initially observed in the
ovalbumin(232-339) sequence . From an examination of several different I-Ad
bindingpeptides, Sette et al . (23) found that they all shared a form ofthis common
sequence . The RNase(43-56) peptide also contained an I-Ad motif(VHESLA) and
this motiffwas used initially to align these two peptide sequences (Fig . 4 A) . In this
alignment the two peptides only had a single identical residue, a valine . We then
generated a series of peptides that contained different assortments ofthese four crit-
ical residues . Each of these peptides was then tested for its ability to stimulate the
TS12 hybridoma (Fig . 4 B) . Substitution of residues Phe-46, His-48, and Leu-51,
which were the positions with absolute specificity, did not result in an active peptide
(RN/HAI) . Likewise substitution of the residues FVHESL (positions 46-51 in bo-
vineRNase) didnot generate a stimulatorypeptide (datanot shown) . We concluded
from these initial resultsthat these four residues were not sufficient to transfer RNase
(43-56) recognition to the HA molecule . To elucidate what other positions in208
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FIGURE 4 .
￿
(A) The amino acid sequence ofRN/HA chimeric peptides. The sequence of the
influenza HA peptide determinant HA(130-144) and RNase(43-56) are shown along with the
two chimeric peptides RN/HAI and RN/HA2 . The amino acid residues are indicated by the
standard single-letter code . The highlighted residues are those from theRNase(43-56) sequence .
(B) The response of TS12 cells to the RN/HA chimeric peptides RN/HAl and RN/HA2 . The
T cell stimulation assaywas performed as described in the Materials and Methods . The values
represent the mean ± SD of triplicate values .
RNase(43-56) were critical for formation of theT cell determinant, we generated
a peptide that included 9 amino acids identical to RNase out of 15 positions . This
hybrid molecule did stimulate the TS12 hybridoma (data not shown) . To further
investigate this initial positive result, a series of chimeric peptides with fewer amino
acids derived from the RNase peptide were generated and functionally tested . When
the Phe-46, His-48, and Leu-51 were transferred along with the Val-54 an active
peptide resulted (RN/HA2) . It should be noted that although only four positions
in theHA backbone were replaced with amino acids fromRNase, there are actually
five residues that correspond to the RNase peptide . This is due to the fact that the
Val-47 is shared by both peptidebackbones . Significantly, theRN/HA2 peptidewas
as stimulatory as the RNase(43-56) peptide . Thus achimeric peptide in which only
5 of the 15 residues were from the RNase(43-56) sequence was fully able to stimu-
late the RNase(43-56)-specific T cells . This result confirms that these five residues
confer all of the specificity of the RNase(43-56) determinant . It should be pointed
out that theVal-47 cannot be identified asacrucialresidue using this chimeric model,
as it is shared by both the original RNase peptide and theHA backbone . One other
interesting observation from this chimeric approach is that the Val-54 was identified
as an important residue forTS12 recognition, even though the other experimental
methods did nothighlight this as a crucial position . From the results reported here,
we cannot determine whether the two valine residues Val-47 and Val-54 are crucial
because of their specific side chains or whetherthey are important because of factors
such as hydrophobicity .
The ReconstructedPeptideRN/HA2 Can Prime In VivoforRNase.
￿
Since we hadshown
that the peptide RN/HA2 could stimulate the TS12 cells as strongly as theRNase(43-56) molecule, we wanted to determine if this chimeric peptide could be
used to prime in vivo for reactivity to the native RNase molecule in vitro. CBA/J
mice were primed with 20 nmol of RN/HA2 and then stimulated in vitro with either
RN/HA2 or native RNase (Fig. 5). TheRN/HA2 peptide was able to primeRNase-
specific Tcells, thus confirming the functional crossreactivity of these two peptides.
Therefore, even though the RNase(43-56) and RN/HA2 peptides only shared 5
residues, they were functionally equivalent in that they could stimulate RNase(43-56)-
specific T cells in vivo and in vitro.
Role ofthe CriticalResidues.
￿
Theindividual amino acid residues ofapeptidedeter-
minant could play one of several different roles. The amino acid residues could be
involved in binding to the Ia molecule, contacting the TCR, determining the con-
formation of the peptide, or simply acting as spacer residues. We next examined
the critical residues of RNase(43-56) and tried to determine which of these roles
they played. We initially determined if the substituted peptides still could bind to
I-A' using a functional competition assay (4). In the autologous system we could
only test thenonstimulatory peptides Y46, R48, and 151 (see Table I for a complete
description of these peptide designations). These results are shown in Table II. The
Y46 peptide was strongly able to compete for the presentation of RNase(43-56),
whereas the R48 and 151 peptides did not compete. These results indicated that the
R48 and 151 peptides were nonstimulatory because they were unable to bind to Ia,
while the Y46 peptide could bind and must be involved in contacting the TCR. By
definition, thesubstituted peptides that canstimulate theTS12 hybridoma are binding
the I-A' molecule, and since the isoleucine substitutions at positions 47 and 54 were
stimulatory they couldnotbe tested in this assay. Thus, ofthe three positionsdirectly
tested, only thePhe-46 could be unequivocally assigned arole ofcontacting the TCR,
and the His-48 and Leu-51 were either involved in contacting la or assisting in the
conformation of the peptide.
Examination ofPhe-46, His-48, Leu-51 UsingIn VivoPrimed TCells.
￿
Theidentification
of the RNase(43-56) determinant in generalused a single T cell hybridoma. To fur-
ther examine these findings in bulk Tcell populations, we tested the abilityof these
substituted peptides to stimulate in vivo primed populations of T cells. This general
approach has been used previously by Schwartz and his colleagues to examine the
role of each of the residues in several cytochrome c peptides (16, 24). We examined
the three critical residues Phe-46, His-48, Leu-51 using the nonstimulatory ana-
logues Y46,R48, and 151. Primed lymph node cells were tested for their ability to
be stimulated by either the native RNase(43-56) or the three substituted peptides .
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FIGURE 5.
￿
The ability of the RN/HA2 peptide to prime
bovine RNase-reactive T cells. CBA/J mice were primed
with 20 nmol of RN/HA2 and alymph node proliferation
assaywas performedasdescribedin MaterialsandMethods.
Thelymphnode cellswere stimulated in vitrowith thein-
dicated concentrations ofeither RN/HA2 or native RNase.
The values shown are themean t SD of triplicate values
from whichthebackground values from culture wellscon-
taining no antigen were subtracted (1,623 t 189). This is
a representative experiment from two separate determi-
nations.210
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TABLE II
Competition for Presentation of RNase(43-56) by Nonstimulatory Analogues
Three nonstimulatory analogues of RNase(43-56) were tested for their ability
to compete for the presentation of RNase(43-56) to TS12 cells as described in
the Materials and Methods . To monolayers of fixed macrophages, 1 AM of
RNase(43-56) was added along with either culture medium, or 32 AM or 100
AM of the indicated peptide . The values represent themean t SD of triplicate
determinations . The percent inhibition was calculated from the formula 100 x
[(cpm of stimulator alone - cpm of stimulator plus competitor/cpm of stimula-
tor alone)] . The sequences of the substituted peptides are given in Table I .
FIGURE 6.
￿
The ability of RNase(43-56) and single amino acid substituted peptides to prime
lymph node cells in vivo andto stimulate in vitro. CBA/J mice were primed with either 20 nmol
of RNase(43-56) or Y46 or with 100 nmol of R48, or 151 . The T cell proliferation assay was
performed as described in the Materials and Methods. The lymph node cells were stimulated
with the indicated peptides in vitro at concentrations from 0.01 to 100AM . For simplicity, only
themaximalvalues whichwere obtained from the 10AM concentration are shown . Theresponse
ofthe lymphnode cells to 100Wg/mlofPPD was included as the positive control andwas 116,013
t 11,486, 31,727 ± 4,367, 57,733 ± 7,185, and 62,970 ± 1,219 for RNase(43-56), Y46, R48,
and 151, respectively. Thevalues shown are the mean f SD of triplicate values from which the
background responses to medium alone have been subtracted (31) . Thebackground values were
11,080 ± 1,495 for RNase(43-56), 2,637 ± 560 for Y46, 2,440 ± 370 for R48, and 2,227 t
521 for 151 .
Competitor
Molar
excess T cell response
cpm x 10-3
Percent
inhibition
Medium - 43 .7 + 0.8
Y46 32 31 .7 t 1 .5 27 .4
100 8.6 + 4.2 80 .4
R48 32 45 .5 t 2.0 -6 .4
100 44 .8 t 1 .7 -2 .6
151 32 44 .7 + 0.8 -2 .3
100 41 .1 + 2.1 5 .9LORENZ ET AL.
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When thecells were in vivo primed with RNase(43-56) and then stimulated in vitro
with either RNase(43-56) or the three single amino acid substituted peptides, it was
observed that theRNase(43-56) showed the best recall stimulation, butthat all three
other peptides were able to stimulate (Fig. 6). When the Y46 peptide was used for
priming, again a good response was detected; however, the RNase(43-56) did not
stimulatenearly as well as thepriming antigen Y46. Thus theY46peptidewaseliciting
a new population of T cells, indicating that this residue was involved in contacting
the TCR. In contrast, the R48 and 151 peptides did not appear to be able to prime
in vivo, even when a fivefold higher concentration of peptide was used for priming.
The results obtained in these experiments are identical to those obtained using the
single cell line and the competition assay, in that the Phe-46 residue appears to be
contacting the TCR, while the His-48 and Leu-51 residues are involved in the
binding/conformation of the peptide.
Discussion
We have previously demonstrated that TS12, the bovine RNase-specific T cell hy-
bridoma used in this study, was specific for the22-mer RNase(40-61). In this report,
we have shown that the 14 amino acid peptide RNase(43-56) can also stimulate the
TS12 hybridoma. Through theuse of apanel of synthetic peptides containing single
amino acid substitutions, we have determined that there are four residues crucial
to the formation of the TS12 determinant, the Phe-46, Val-47, His-48, and Leu-51 .
ThePhe-46 was determined to be aTCR contact residue, while the otherthreeresidues
either function in Ia contact or peptide conformation. To test the critical nature of
these four amino acids, they were substituted into the unrelated peptide backbone
HA(130-144). This chimeric peptide (RN/HA1) was not able to stimulate the TS12
hybridoma. However, when only one additional aminoacid residue from the RNase
peptide, Val-54, was substituted into the HA backbone, stimulation of the TS12 hy-
brid was seen. Theactivity of this peptidewas equivalent to the native RNase(43-56)
in vitro and it was able to prime RNase-specific T cells in vivo. In brief, our studies
have shown that these five amino acids from the RNase sequence are necessary and
sufficient for RNase(43-56)-specific T cell stimulation.
There have been two previous reports of generating chimeric peptides. Guillet
et al. were able to transfer three residues of the 12-26 determinant of the cIR to
the very similar sequence of Nase(66-78) and create an active peptide (25). The
residues that were substituted were chosen becausethey were theonly three residues
that were not either identical or conservative substitutionsbetween thecIR andNase
determinants. They were also able to transfer the same three residues to the un-
relatedovalbumin sequence (324-336)and again create an active neo-peptide. Both
of these chimeric peptides were active, but -1,000-fold weaker than the native 12-26
molecule. Rothbard et al. generated chimeric peptides between the HA(307-319)
determinant and the matrix(17-29) (26). The overall strategy used involved the sub-
stitution of residues predicted to be on one face of an ci-helix. Using this procedure,
they were able to generate an active chimeric peptide by substituting 7 of 13 residues.
The resultingpeptide was -300-fold weaker than the native HA(307-318) molecule.
When 10 of the 13 residues were substituted, the resulting peptide was nearly as
active as the native HA(307-318) peptide. Although our strategy for identifying the
critical residues was different, our results are similar to those of Guillet et al. (25)212
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and Rothbard et al. (26). A major difference is that we were able to generate chi-
meric peptides that were nearly as active as the native sequence, and that we were
able to show that in vivo the native and the chimeric peptide appeared to be func-
tionally identical in their ability to prime for T cell responses.
During our examination of chimeric peptides, we have gained an appreciation
ofthe sensitive nature ofthe antigenic determinants recognized by T cells. We have
found that many of the nonstimulatory chimeric peptides are not able to bind to
I-Ak. Thus it appears that in order to successfully generate a chimeric peptide, one
has to transferthe residuesthat contact the TCR orthe lamolecule, aswellas neigh-
boring residues that will permit thecorrect conformation to be formed. An example
ofthe fragile nature of these determinants is seen ifone takes the RN/HA2 peptide
and replaces the Gly-55 with Gln-55 from the RNase(43-56) sequence, the resulting
peptide is now completely inactive (datanot shown). By replacing an additional res-
idue of the chimeric peptide RN/HA2, one has completely destroyed the activity
of the peptide. This phenomenon has been previously observed by Rothbard and
his colleagues during their examination of the series of HA/matrix chimeric pep-
tides. Replacing 7 of 13 residues generated an active peptide, whereas replacing 8
of 13 resulted in an inactive peptide (26). Therefore, our previous classification of
the residues of a determinant into T cell contact, la contact, and spacer residues
should now be extended toinclude residues that are involved in allowing thepeptide
to adopt the correct conformation. To generate active chimeric peptides one has to
include other residues, inaddition to theT cell and lacontact residues. These addi-
tional amino acids permit or assist the peptide into adopting the correct conforma-
tion to bind to an Ia molecule and be recognized by the T cell.
As we have discussed previously, the RNase(43-56) determinant is predicted by
several ofthe current methods for predicting T cell epitopes. It is predicted by the
DeLisi and Berzofsky amphipathic a-helix algorithm (27) and it contains a Roth-
bard motif(ESLAD) (28). The RNase(43-56) determinant also possesses the I-Ad
motif(23), although H-2d mice do not respond to the RNase(43-56) peptide (data
not shown). The three predictive methods are not mutually exclusive and for the
RNase(43-56) determinant are probably identifying the same common feature.
In this study, we observed that substitution of conservative amino acid residues
for the His-48 or Leu-51, dramatically decreased the resulting peptide's ability to
bind to the I-A' molecule. Similar results were obtained when the HEL(52-61) de-
terminant was analyzed (14). Thus for these two determinants, the replacement of
a single critical residue could almost completely abrogate a peptide from binding
to I-A'. These results are contrasted by those obtained from detailed examinations
oftwo otherdeterminants. Sette et al. found that for the ovalbumin(323-339) deter-
minant (15), no single conservative substitutiondramatically affected apeptide'sability
to bind. When the determinant HEL(34-45) was similarlyanalyzed, again the sub-
stitution of no single amino acid residue completely abolished binding (Lambert,
L. E., and E. R. Unanue, manuscript submitted for publication). Thus, from this
limited sample it appears that determinants can be divided into two groups; one
in which an individual amino acid residue appears to play a major role in binding
to an la molecule, and another inwhich the binding to an Ia molecule must be due
to the collective binding of several different amino acid residues.
During the examination ofthe critical residues, we identified that the Phe-46 ap-LORENZ ET AL.
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peared to contribute the majority of the T cell specificity. This residue could not
be replaced with even the closely related tyrosine residue and in vivo priming with
substitutions at this position elicited unique populations of T cells. When we have
examined other peptide determinants we have also found that, in general, one or
two positions seem to predominate in determining the T cell specificity (14; ourun-
published observation). There are other residues in RNase(43-56) that most likely
are contacting the TCR, but the Phe-46 residue appears to determine most of the
specificity.
Another interesting aspect from this examination involved the length of the
RNase(43-56) determinant. Four of the five critical residues are contained in the
6-mer 46-51, and when tested, this peptide did not stimulate the TS12 cells, even
at a concentration of 10 mM. All five of the critical residues were contained in the
9-mer46-54 (Table 1) . When this peptide was tested forits abilityto stimulate TS12
cells, we detected only a very weak response at 100 uM, which made the stimulation
by this peptide 10,000 times weaker than the native RNase(43-56) (data notshown).
Even though this 46-54peptide contained all ofthecritical residues, there appeared
to be a requirement for residues on either side of this core. The specificity of these
residues was not very stringent since they could individually be replaced with ala-
nine residues, or collectively replaced with the residues from the HA(130-144) se-
quence. We believe that theseother residues could be involved in secondarybinding
events to the la molecule or be required forthe peptide to adapt the correct confor-
mation . There has been a recent report of a class I-restricted epitope that could
be represented by a pentapeptide which contained the Rothbard motif (29). Our
findings with the RNase(43-56) determinant are different, in that either a 6-mer
or a 9-mer, both of which contained the Rothbard motif, were essentially not active.
Thedifference between these two results could be due to the sensitivity of the assay
systems used or simply reflects a difference between the two determinants.
Since we were able to regenerate the RNase(43-56) determinant by transferring
only five residues, the question arises as to how frequently this pattern of amino
acid residues occurs. One could envision the potential for crossreactive T cell deter-
minants if only five residues are needed. We searched the Protein Identification Re-
source data base(Release 17 .0; June 30, 1988; 5407 sequences; 1,448,175 residues)
for the occurrence of the FVHXXLXXV sequence, where the X represents any
amino acid residue. Excluding related ribonuclease molecules, only a single example
of this sequence was found, that being residues 834-842 from the glycoprotein
precursorof the Rift Valley fevervirus(FVHTYLQSV). Thus, even though a deter-
minant can be recreated from five residues, the rare occurrence of this sequence
pattern is consistent with the observation that T cell responses are highly specific.
Summary
The involvement of each of the amino acid residues of the I-A'-restricted T cell
determinant RNase(43-56) was examined in detail using a series of peptides con-
taining single amino acid substitutions. Four positions were identified as being es-
sential for the formation of the determinant, Phe-46, Val-47, His-48, and Leu-51.
When these four residues were substituted into the backbone of the unrelated pep-
tide HA(130-144), a nonstimulatory peptide was obtained. The inclusion of an ad-214
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ditional residue, Val-54, resulted in achimeric peptide, RN/HA2, which was nearly
as active as the native molecule. The peptide RN/HA2 was able to prime in vivo
forRNase reactivity, confirming that thesefive residues containedallofthe specificity
of the RNase(43-56) determinant. The role of three of these critical residues was
examined using both a functional competition assay and an in vivo priming assay.
It was ascertained that the Phe-46 was directly involved in contacting the TCR, while
the His-48 and Leu-51 were either involved in binding to the I-A' molecule or in
determiningthe conformation of thepeptide. Thus, by critically evaluating the con-
tribution of each of the amino acid residues in a T cell determinant, we were able
to generate a chimeric peptide only containing 5 of 15 residues from the RNase(43-56)
sequence that was functionally identical to the native RNase(43-56) molecule both
in vitro and in vivo.
We would like to thank D. Donermeyer and B. Raynor for technical assistance.
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